Amgen : AMGN

All Amgen Articles

701 Articles

Douglas A. McIntyre | Apr 24, 2009 at 6:30 AM EDT

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

These are among the top research calls and analyst upgrades and downgrades we have seen early this Friday morning with…

Douglas A. McIntyre | Apr 23, 2009 at 3:27 PM EDT

Amgen Back To Doldrums (AMGN)

Amgen Inc. (NASDAQ: AMGN) has posted some very highly anticipated and uninteresting earnings. The biotech giant reported $0.98 EPS net…

Douglas A. McIntyre | Apr 17, 2009 at 2:05 PM EDT

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association…

Douglas A. McIntyre | Mar 27, 2009 at 6:59 AM EDT

Top 10 Analyst Upgrades & Downgrades (AMGN, COP, DD, GENZ, GS, MON, MOS, BBY, PBR, VMW)

These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning:…

Douglas A. McIntyre | Feb 20, 2009 at 5:08 AM EST

Ten Large American Companies That Won’t Cut Jobs

Layoffs at big companies are so common now that it is novel when a day goes by without Microsoft (MSFT),…

Douglas A. McIntyre | Feb 5, 2009 at 5:57 PM EST

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know…

Douglas A. McIntyre | Jan 5, 2009 at 7:15 AM EST

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT…

Douglas A. McIntyre | Dec 10, 2008 at 11:04 AM EST

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

It seems that short sellers have no real direction in the major NASDAQ biotech stocks from mid-November to late-November. Generally…

Douglas A. McIntyre | Dec 9, 2008 at 10:10 AM EST

The 24/7 Wall St. CEO Of The Year: James A. Skinner Of McDonald’s (MCD)

Today 24/7 Wall St.named its annual CEO of the Year James A. Skinner of McDonald’s (MCD). He was picked from…

Douglas A. McIntyre | Dec 7, 2008 at 2:06 PM EST

CEO Of The Year Nominees: 8) Kevin W. Scharer Of Amgen (AMGN)

24/7 Wall St. will name its annual CEO of the Year next week. The executive will be picked from a…

Douglas A. McIntyre | Oct 22, 2008 at 3:15 PM EDT

Amgen Becomes A Biotech Safety Stock (AMGN)

Amgen Inc. (NASDAQ: AMGN) has just posted earnings. The biotech giant for anemia treatments posted $1.09 GAAP EPS and adjusted…

Douglas A. McIntyre | Oct 2, 2008 at 7:16 AM EDT

Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)

These are some of the top upgrades we are seeing from Wall Street analysts this morning: Amgen (AMGN) Raised to…

Douglas A. McIntyre | Sep 17, 2008 at 2:55 AM EDT

Media Digest 9/17/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

According to Reuters, the federal government bailed out AIG (AIG) The Fed will loan the insurance company $85 billion for…

Douglas A. McIntyre | Aug 13, 2008 at 5:49 AM EDT

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen…

Douglas A. McIntyre | Aug 4, 2008 at 6:30 AM EDT

Top Pre-Market Analyst Upgrades (AKAM, AIV, AMGN, CNX, KND, MCO, NEU, PH, SE)

These are some of the key analyst upgrades and positive calls we have seen early this Monday morning with over…

1 … 41 42 43 44 45 … 47

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

Amgen Back To Doldrums (AMGN)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Top 10 Analyst Upgrades & Downgrades (AMGN, COP, DD, GENZ, GS, MON, MOS, BBY, PBR, VMW)

Ten Large American Companies That Won’t Cut Jobs

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

The 24/7 Wall St. CEO Of The Year: James A. Skinner Of McDonald’s (MCD)

CEO Of The Year Nominees: 8) Kevin W. Scharer Of Amgen (AMGN)

Amgen Becomes A Biotech Safety Stock (AMGN)

Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)

Media Digest 9/17/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Top Pre-Market Analyst Upgrades (AKAM, AIV, AMGN, CNX, KND, MCO, NEU, PH, SE)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Amgen : AMGN

All Amgen Articles

Top Analyst Upgrades & Downgrades (AMGN, CS, BEAT, DV, MAR, MSFT, RIMM, SPWRA, TOL)

Amgen Back To Doldrums (AMGN)

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Top 10 Analyst Upgrades & Downgrades (AMGN, COP, DD, GENZ, GS, MON, MOS, BBY, PBR, VMW)

Ten Large American Companies That Won’t Cut Jobs

Can Biogen Idec Earnings Generate A Buyout? (BIIB, AMGN, GILD, GENZ, CELG, MRK, SNY, GSK)

Is Pfizer About To Be On Acquisition Path? (PFE, AMGN, WYE, GILD, BMY, LLY, SGP, CELG, GENZ, BIIB)

Short Sellers, No Direction in Biotech (AMGN, BIIB, CELG, GENZ, GILD)

The 24/7 Wall St. CEO Of The Year: James A. Skinner Of McDonald’s (MCD)

CEO Of The Year Nominees: 8) Kevin W. Scharer Of Amgen (AMGN)

Amgen Becomes A Biotech Safety Stock (AMGN)

Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)

Media Digest 9/17/2008 Reuters, WSJ, NYTimes, FT, Bloomberg

24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)

Top Pre-Market Analyst Upgrades (AKAM, AIV, AMGN, CNX, KND, MCO, NEU, PH, SE)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings